1. Home
  2. VCEL vs PNTG Comparison

VCEL vs PNTG Comparison

Compare VCEL & PNTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCEL
  • PNTG
  • Stock Information
  • Founded
  • VCEL 1989
  • PNTG 2019
  • Country
  • VCEL United States
  • PNTG United States
  • Employees
  • VCEL N/A
  • PNTG 7000
  • Industry
  • VCEL Biotechnology: Biological Products (No Diagnostic Substances)
  • PNTG Medical/Nursing Services
  • Sector
  • VCEL Health Care
  • PNTG Health Care
  • Exchange
  • VCEL Nasdaq
  • PNTG Nasdaq
  • Market Cap
  • VCEL 2.1B
  • PNTG 851.3M
  • IPO Year
  • VCEL 1997
  • PNTG N/A
  • Fundamental
  • Price
  • VCEL $31.57
  • PNTG $24.61
  • Analyst Decision
  • VCEL Strong Buy
  • PNTG Buy
  • Analyst Count
  • VCEL 6
  • PNTG 6
  • Target Price
  • VCEL $60.60
  • PNTG $35.00
  • AVG Volume (30 Days)
  • VCEL 811.4K
  • PNTG 335.0K
  • Earning Date
  • VCEL 11-06-2025
  • PNTG 11-05-2025
  • Dividend Yield
  • VCEL N/A
  • PNTG N/A
  • EPS Growth
  • VCEL 2045.40
  • PNTG 20.56
  • EPS
  • VCEL 0.13
  • PNTG 0.77
  • Revenue
  • VCEL $249,119,000.00
  • PNTG $798,923,000.00
  • Revenue This Year
  • VCEL $18.35
  • PNTG $28.29
  • Revenue Next Year
  • VCEL $22.47
  • PNTG $11.61
  • P/E Ratio
  • VCEL $224.93
  • PNTG $31.91
  • Revenue Growth
  • VCEL 16.13
  • PNTG 30.58
  • 52 Week Low
  • VCEL $29.94
  • PNTG $21.18
  • 52 Week High
  • VCEL $63.00
  • PNTG $37.13
  • Technical
  • Relative Strength Index (RSI)
  • VCEL 41.35
  • PNTG 48.94
  • Support Level
  • VCEL $29.93
  • PNTG $23.68
  • Resistance Level
  • VCEL $33.25
  • PNTG $26.11
  • Average True Range (ATR)
  • VCEL 1.72
  • PNTG 0.80
  • MACD
  • VCEL -0.17
  • PNTG 0.00
  • Stochastic Oscillator
  • VCEL 22.09
  • PNTG 38.21

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

About PNTG The Pennant Group Inc.

Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.

Share on Social Networks: